As with anything new, our implementation of Technegas (Cyclomedica USA) provided a mixed bag of opportunities and challenges. Naturally there was excitement but also anxiety. Our institution is accustomed to conducting clinical trials and performing technically complex examinations, with our nuclear
No takes yet. Share an insight, caveat, or question.
Linscheid et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: